PharmaLundensis AB
PHAL | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0003359710 (+5 more)
- LEI:
- 54930082I88D5N3GQ506
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://pharmalundensis.se/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Tord Staffan Håkan Skogvall | Other | Buy | 2,337 | 1,986.45 SEK |
| 2025-01-17 | SkåneÖrnen AB | Other | Buy | 121,700 | 96,143.00 SEK |
| 2025-01-17 | Tord Staffan Håkan Skogvall | Other | Buy | 10,958 | 7,999.34 SEK |
| 2024-10-14 | SkåneÖrnen AB | Other | Buy | 49,370 | 19,748.00 SEK |
| 2024-10-09 | Tord Staffan Håkan Skogvall | Other | Buy | 27,936 | 10,336.32 SEK |
| 2024-09-26 | SkåneÖrnen AB | Other | Buy | 63,000 | 29,610.00 SEK |
| 2024-09-20 | Bo Wennergren | Other | Buy | 60,000 | 27,600.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg?Expires=1750354064&Signature=OpZYueNAxNqoRf8HKRJLivLJ6PSfLCYOn2if7NYrVuAFngYtUfvcL3g181givIatdTzFJE3aRGqYrvwK9ajwxCDc-7krM4AkkldF9ZWZahfZ0M86yVEZmOGZ5G99k6wTtW4Tfis0lPHsCr252Uc8KlTfRkAbipmftj1cCKYbOVHqqjnNIPCakAsY3uiomzgUOAiPdbtm7Uv68p2XUcYSvf8yMeOkQOQMzZ3xbz4J1Bg8MYydUzO6f7NSkn9XWkcg6o~umAi9e4jdw2qPaoyKXTBywyFe~0U9yGEaLr8CnxobgOwDmoonW~P6CY9mosV6jctANICZzn4PhrI9zUA78A__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT | |
|
Stayble Therapeutics AB | Sweden | STABL | |
|
Stem Cells Spin Spolka Akcyjna | Poland | SCS | |
|
Strategic Partners A/S | Denmark | STRAP | |
|
STRIX GROUP PLC | Isle of Man | KETL |